Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Conversion Director acquired 249,998 shares (conversion)
  2. 4 Conversion Director acquired 62,500 shares (conversion)
  3. 4 Conversion Director acquired 10,756,249 shares (conversion)
  4. 4 Conversion Director acquired 250,000 shares (conversion)
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 424B4 Offering Prospectus
  16. CT ORDER Other Confidential Order
  17. EFFECT Other Notice of Effectiveness
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 38 of 40 · 789 filings